BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230829
DTEND;VALUE=DATE:20230902
DTSTAMP:20260516T065808
CREATED:20230503T044916Z
LAST-MODIFIED:20230503T044916Z
UID:37116-1693267200-1693612799@www.pharmajournalist.com
SUMMARY:8th CAR-TCR Summit
DESCRIPTION:Last year was momentous for the cell therapy field: it was the year that CAR-T therapies became CURATIVE. \nThis decade of success has resulted in explosive investment into the development of CAR and TCR based approaches to ensure more patients around the world can benefit from these lifesaving therapies.   \nThe 8th CAR-TCR Summit is returning to Boston as the industry’s trusted\, definitive\, end-to-end forum for the global network of autologous and allogeneic cell therapy drug developers. Ensure your whole team stays ahead of the curve with unmatched industry insights shared across discovery through to commercialization.   \nAcross 3 conference days with 8 content tracks\, and an additional 6 deep-dive workshops\, bootcamp\, focus day\, diversity session\, C-level think tank and more\, 200+ CAR and TCR experts will lead you and over 1\,000 peers in discussions that will accelerate your pipeline\, bringing better drugs to patients faster. \nTo know more visit: https://ter.li/ztgick
URL:https://www.pharmajournalist.com/event/8th-car-tcr-summit/
LOCATION:Hynes Convention Center\, 900 Boylston St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230905
DTEND;VALUE=DATE:20230908
DTSTAMP:20260516T065808
CREATED:20230515T131825Z
LAST-MODIFIED:20230515T131825Z
UID:37179-1693872000-1694131199@www.pharmajournalist.com
SUMMARY:5th Exosomes Based Therapeutic Development Summit
DESCRIPTION:The 5th Exosome Based Therapeutic Development Summit returns with a refreshed program\, with data-driven insights from those pioneering the field who are dedicated to the clinical translation and commercialization of exosome-based therapeutics across a broad range of disease indications. \nThis year features a brand-new focus day on analytical development\, diving into characterization assays\, purification\, and potency assays to enable robust translation into the clinic. \nThis is the most comprehensive\, end-to-end meeting for industry personnel who are looking to fine-tune molecular components of exosomes\, achieve GMP manufacturing of EVs for clinical applications\, and successfully deliver payloads to the target tissue by evaluating route of administration to accelerate candidates towards commercialization. \nThe 2023 conference covers: \n\nEmerging standardized analytical strategies for optimized characterization\, purification\, and isolation to improve batch consistency and reproducibility towards successful scale-up\nKey pre-clinical and clinical updates across a range of therapeutic areas\nThe latest advancements of targeted delivery and therapeutic payloads\nThe challenges of large-scale manufacturing\nNavigating the complex regulatory landscape across the drug development timeline\n\nView the full agenda here: https://ter.li/q4fnpd
URL:https://www.pharmajournalist.com/event/5th-exosomes-based-therapeutic-development-summit/
LOCATION:Hilton Boston Logan Airport\, One Hotel Dr\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230905
DTEND;VALUE=DATE:20230908
DTSTAMP:20260516T065808
CREATED:20230519T095236Z
LAST-MODIFIED:20230519T095236Z
UID:37210-1693872000-1694131199@www.pharmajournalist.com
SUMMARY:4th Annual Gene Therapy Immunogenicity Summit 2023
DESCRIPTION:The 4th Annual Gene Therapy Immunogenicity Summit is your opportunity to connect with likeminded peers from gene therapy drug developers\, along with leading academics\, regulators\, and key service providers\, all making strides with improving risk assessments\, monitoring\, and mitigating against AAV gene therapy immunogenicity. \nRegistering for 2023 will grant you access to keynote plenaries from leading gene therapy figures\, deep-dive discussions into pressing preclinical and clinical developments\, and highly appraised networking opportunities with 150+ of your peers\, all to leave you with the actionable tools\, insights\, and connections you need to enhance your immunogenicity-focused work. \nTo know more visit: https://ter.li/vk8xwq
URL:https://www.pharmajournalist.com/event/4th-annual-gene-therapy-immunogenicity-summit-2023/
LOCATION:Hilton Boston Back Bay\, 40 Dalton St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230905
DTEND;VALUE=DATE:20230909
DTSTAMP:20260516T065808
CREATED:20230606T104920Z
LAST-MODIFIED:20230606T104920Z
UID:37280-1693872000-1694217599@www.pharmajournalist.com
SUMMARY:13th World Clinical Biomarkers & CDx Boston 2023
DESCRIPTION:The hotly anticipated 13th World Clinical Biomarkers & CDx Summit returns as the only industry-led meeting uniting 600+ senior decision makers in the biomarker and CDx field to accelerate clinically validated and affordable co-development of drug-CDx by overcoming commercialization\, reimbursement and regulatory challenges in oncology and beyond to bring personalized medicine to patients faster. \nWhether you are working in Oncology\, NASH\, or Neuroscience\, join 600+ Directors\, Heads and VPs of Clinical Biomarkers\, Translational Medicine\, Precision Medicine & Companion Diagnostics together with drug and diagnostic developers\, regulatory experts\, payors and notified bodies for an exclusive opportunity of knowledge sharing and networking to propel your pipelines and make a marked difference for patient outcomes. \nTo know more visit: https://ter.li/849j6q
URL:https://www.pharmajournalist.com/event/13th-world-clinical-biomarkers-cdx-boston-2023/
LOCATION:Omni Boston Hotel at the Seaport\, 450 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230911
DTEND;VALUE=DATE:20230914
DTSTAMP:20260516T065808
CREATED:20230704T143300Z
LAST-MODIFIED:20230704T143518Z
UID:37419-1694390400-1694649599@www.pharmajournalist.com
SUMMARY:7th Complement-Based Drug Development Summit
DESCRIPTION:With the recent FDA approval of SYFOVRE and more decisions and approvals expected in 2023\, the Complement-Based Drug Development Summit is returning for its 7th year in a timely fashion. Be the first to view this year’s Event Guide below! \n7th Complement-Based Drug Development Summit\nSeptember 11-13\, 2023\nView Agenda \nReuniting experts across Nephrology\, Neurology\, Ophthalmology\, and Haematology\, join the leading companies showcasing the latest preclinical and clinical progress for complement-based therapeutics. \n\nWith 30+ expert speakers from: AGTC\, Alexion\, Alnylam\, Amgen\, Annexon\, Apellis – and that’s just the A’s!\nCovering more complement targets than ever before including C5aR2\, Factor Bb and Combination Therapy\, alongside an increased coverage of diseases\nFull of content for your whole team covering the most pressing challenges – from evaluating the value proposition of different fragments to target to designing clinical trials with high-risk patient populations\n\n \n​​​​View the full list of sessions and expert speakers here. \n​​​​​​This world-class speaker faculty will evaluate the entirety of the complement landscape\, from scientific understanding to strategic\, commercial intelligence. This means that no matter your role in the field\, you’ll leave with tangible insights to further develop your complement pipeline.
URL:https://www.pharmajournalist.com/event/7th-complement-based-drug-development-summit/
LOCATION:Hilton Boston Logan Airport\, One Hotel Dr\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230912
DTEND;VALUE=DATE:20230915
DTSTAMP:20260516T065808
CREATED:20230714T121304Z
LAST-MODIFIED:20230714T121304Z
UID:37455-1694476800-1694735999@www.pharmajournalist.com
SUMMARY:LNP Characterization & Analytical Development Summit
DESCRIPTION:Fingerprinting Your LNP Drug Product Quality\, Safety\, Efficacy & Regulatory Compliance \nWith the recent breakthroughs from Verve Therapeutics\, Vertex-Arbor Bio\, and Mana.bio propelling the field of LNP technology forward at lightning speed beyond mRNA vaccines\, the LNP Characterization & Analytical Development Summit is your must-attend meeting to deep dive into the latest technologies and approaches throughout product lifecycle and strengthen your lipid nanoparticle characterization\, bioanalytical and assay development competencies. \nWith unmissable case studies from the likes of Pfizer\, Moderna\, AstraZeneca\, Ultranegyx\, Merck and SINTEF\, this is the definitive forum to benchmark and learn with the LNP community who unite for the first time. \nThese industry titans have collaborated to form a comprehensive\, 3-day program covering key topics including: \n\nAnalyze LNP structure and morphology to relay into functional data and analytical practices with Ultragenyx and Pfizer\nOptimize the characterization of payloads to foresee the outcome of the LNP complex with Hopewell Therapeutics\, Beam Therapeutics and Moderna\nDevelop assays which align with mechanisms of action and portray total functionality of the LNP with NIST\, Editas Medicine and AstraZeneca\n\nDon’t miss this opportunity to supercharge your analytics\, and together with 60+ characterization and analytical scientists\, get inspiration to derive best practice\, and support next generation of therapeutics to patients with safety and efficacy. \nTo know more visit: https://ter.li/z7dmih
URL:https://www.pharmajournalist.com/event/lnp-characterization-analytical-development-summit/
LOCATION:Hilton Boston Back Bay\, 40 Dalton St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230912
DTEND;VALUE=DATE:20230915
DTSTAMP:20260516T065808
CREATED:20230720T121753Z
LAST-MODIFIED:20230720T121753Z
UID:37490-1694476800-1694735999@www.pharmajournalist.com
SUMMARY:3rd Rare & Genetic Kidney Disease Drug Development Summit
DESCRIPTION:Your one-stop shop to capturing industry’s most exciting developments to tackle rare & genetic kidney diseases. From evaluating real-world outcomes to uncovering underlying pathophysiology to interrogating translational models\, the 3rd Rare & Genetic Kidney Disease Drug Development Summit is uniquely positioned to give industry the opportunity to unite towards a shared goal and share strategic insights to move from bench to bedside and bring efficacious therapies to patients faster. \nTo know more visit: https://ter.li/jy2ot0
URL:https://www.pharmajournalist.com/event/3rd-rare-genetic-kidney-disease-drug-development-summit/
LOCATION:Hilton Boston Back Bay\, 40 Dalton St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230913
DTEND;VALUE=DATE:20230915
DTSTAMP:20260516T065808
CREATED:20230810T114925Z
LAST-MODIFIED:20230810T114925Z
UID:37605-1694563200-1694735999@www.pharmajournalist.com
SUMMARY:Wearable Injectors and Connected Devices USA
DESCRIPTION:Wearable Injectors and Connected Devices USA  \nConference: September\, 13 – 14 2023  \nBoston\, USA  \nWebsite: http://www.wearableinjectors-usa.com/PharmaJournalist-EL \nAdvancing digital health and on-body drug delivery devices for enhanced patient experience  \nFollowing the success of the Wearable Injectors and Connected Devices Europe conference\, SAE Media Group will be bringing the conference to Boston to cater to Big Pharma\, Biotech and Device Developers in the USA. \nAs the need for at home self-administration and routes for delivery of time-dependent and high-volume drug delivery grows\, on-body injectors and connected devices hold great opportunity. The conference will delve into on-body device design and development\, latest advances in connectivity and digital integration of wearable devices\, and opportunities for enhancement of user-interface through human factors case studies. The conference will also address challenges in regulations surrounding wearable injectors and connected devices with case studies and an FDA keynote on cybersecurity. \nAs part of SAE Media Group’s leading Injectable series of conferences\, we bring together high-level experts from big pharma and device developers to network and share knowledge to advance R&D. The two-day conference will not only bring you high-quality key insights needed to enhance your wearable devices and connected product portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in September 2023! \nKey Reasons to Attend: \n\nDiscover the latest advances in wearable injector design and development as well as emerging technologies for improved drug delivery\nUnderstand and gain insight into the regulations surrounding electronic devices and wearable injectors such as labelling requirements and clinical study expectations\nDelve into the digital integration of medical devices for improved user experience and strategies to ensure connected ecosystems are safe with an FDA Cybersecurity update\nBenchmark against connected injector case studies and gain insight into key considerations during development such as battery selection\nEngage in the latest strategies for implementing user centricity into device design to meet patient needs and increase adherence\n\nWHO SHOULD ATTEND? \nDevice Developers \nCombination Product Developers \nSmart Packaging Developers and Designers \nSmart Device Developers \nDrug- Delivery Developers \nConnected/Digital Health Developers
URL:https://www.pharmajournalist.com/event/wearable-injectors-and-connected-devices-usa/
LOCATION:Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, 02199\, United States
ORGANIZER;CN="SAE MEDIA GROUP":MAILTO:events@saemediagroup.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230919
DTEND;VALUE=DATE:20230922
DTSTAMP:20260516T065808
CREATED:20230726T074357Z
LAST-MODIFIED:20230726T074357Z
UID:37521-1695081600-1695340799@www.pharmajournalist.com
SUMMARY:7th IPF Summit
DESCRIPTION:FIbroGen’s recent Phase 3 trial failure for pamrevlumab exemplifies the critical time point the pulmonary fibrosis field is currently at as drug developers move through in-human to Phase 2 to Phase 3 trials to get the next disease-modifying drug to the patients in need. \nThe 7th IPF Summit (September 19-21 | Boston) returns at this crucial stage for the drug development and academic communities to come together to address R&D bottlenecks\, troubleshoot key discovery challenges\, and share exclusive data to accelerate the latest ideas and innovations in the IPF field and supercharge a new era of IPF therapeutics. \nIf you haven’t yet seen the line-up of 42+ expert speakers\, take a look at the full program in the event guide! \nAre you looking to address and solve challenges with IPF therapeutic development\, such as:   \n\nUnderstanding cell cross-talk in the lung pathobiology of IPF\, including epithelial and endothelial cells\nHarnessing precision medicine for IPF including patient selectivity\, combinational therapies\, and biomarkers\nWhether to incorporate imaging into your preclinical and clinical development and the potential of using imaging as an endpoint in IPF?\n\nThen this is the event for you! This is your unique opportunity to leverage knowledge from world-leading IPF industry experts and KOL academics on the latest developments to overcome\, discovery\, preclinical\, translational\, and clinical\, challenges of IPF therapeutic development for successful advancement of therapeutic candidates to in-human studies and beyond. \nJoin experts from the likes of Boehringer Ingelheim\, Genentech\, Pfizer\, AstraZeneca\, BMS\, Pliant\, Galecto\, Vicore\, Avalyn\, Pieris\, Moderna\, Takeda and more who have already saved their places at the meeting. \nSee pricing and registration options here!
URL:https://www.pharmajournalist.com/event/7th-ipf-summit/
LOCATION:Westin Boston Seaport\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230926
DTEND;VALUE=DATE:20230929
DTSTAMP:20260516T065808
CREATED:20230704T142733Z
LAST-MODIFIED:20230704T142733Z
UID:37413-1695686400-1695945599@www.pharmajournalist.com
SUMMARY:2nd mRNA Process Development & Manufacturing Summit
DESCRIPTION:Returning to Boston as the world’s only industry-leading meeting focused on mRNA process development and manufacturing\, join 200+ VPs\, Directors and Heads of Process Development\, MSAT\, Technical Operations\, CMC and more from large pharma\, innovative biotechs\, and academia. \nDownload the program here: https://ter.li/5o4hdl \nThis must-attend meeting will provide you with technical insight and know-how from the largest process development and manufacturing speaker faculty to date\, enabling you to revolutionize your processes for effective industrialization. \nSpanning three tracks dedicated to Research Scale\, IND-Enabling & Clinical Scale\, and Commercial Scale\, this year’s meeting will dive deep into the challenges\, requirements\, innovations and opportunities to improve your design\, development and scale-up solutions from drug substance to drug product for regulatory and market readiness. \nRegister here: https://ter.li/nu15iq
URL:https://www.pharmajournalist.com/event/2nd-mrna-process-development-manufacturing-summit/
LOCATION:Boston Convention and Exhibition Center (BCEC)\, 415 Summer Street\, Boston\, MA\, MA 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR